Could a pill end motion sickness for good?
NCT ID NCT06138613
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests an oral drug called tradipitant in 705 adults with a history of motion sickness. The goal is to see if it is safe and can ease symptoms during real travel. Participants take the drug before or during trips, and researchers monitor side effects and how well it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tradipitant (oral capsule)
What this could lead to
If it works, this could provide a new medication option to prevent or reduce motion sickness during travel.
What could go wrong
This is an open-label study (no placebo), so results may be biased. It is still experimental, and side effects or lack of effectiveness are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MOTION SICKNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Santa Monica Clinical Trials
Santa Monica, California, 90404, United States